Literature DB >> 16368979

Target antigen, age, and duration of antigen exposure independently regulate immunoglobulin G subclass switching in malaria.

J Eric Tongren1, Christopher J Drakeley, Suzanna L R McDonald, Hugh G Reyburn, Alphaxard Manjurano, Watoky M M Nkya, Martha M Lemnge, Channe D Gowda, Jim E Todd, Patrick H Corran, Eleanor M Riley.   

Abstract

The isotype/subclass of immunoglobulin determines antibody function, but rather little is known about factors that direct class switching in vivo. To evaluate factors that might influence the maturation of the antibody response during infection, we conducted a seroepidemiological study of the immunoglobulin G (IgG) subclass response to four merozoite-associated antigens of Plasmodium falciparum in a mountainous region of northeastern Tanzania, where malaria endemicity declines with increasing altitudes. We found that IgG1/IgG3 class switching is independently affected by the nature of the antigen, cumulative exposure to the antigen, and the maturity of the immune system (i.e., the age of the individual). These observations provide insights into the effects of immune system maturity, the duration and intensity of antigen exposure, and inherent characteristics of individual antigens on the process of class switching in human B cells. Our data also throw light on the consequences of class switch decisions on the gradual acquisition of antimalarial immunity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16368979      PMCID: PMC1346665          DOI: 10.1128/IAI.74.1.257-264.2006

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses.

Authors:  D J Conway; D R Cavanagh; K Tanabe; C Roper; Z S Mikes; N Sakihama; K A Bojang; A M Oduola; P G Kremsner; D E Arnot; B M Greenwood; J S McBride
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

Review 2.  Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology.

Authors:  J Sloan-Lancaster; P M Allen
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

3.  Humoral and cell-mediated immunity to the Plasmodium falciparum ring-infected erythrocyte surface antigen in an adult population exposed to highly endemic malaria.

Authors:  H P Beck; I Felger; B Genton; N Alexander; F al-Yaman; R F Anders; M Alpers
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

4.  Role of neutrophil Fc gamma RIIa (CD32) and Fc gamma RIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes.

Authors:  R G Bredius; C A Fijen; M De Haas; E J Kuijper; R S Weening; J G Van de Winkel; T A Out
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

Review 5.  B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms.

Authors:  Q Vos; A Lees; Z Q Wu; C M Snapper; J J Mond
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

6.  Identification of recombinant filarial proteins capable of inducing polyclonal and antigen-specific IgE and IgG4 antibodies.

Authors:  O Garraud; C Nkenfou; J E Bradley; F B Perler; T B Nutman
Journal:  J Immunol       Date:  1995-08-01       Impact factor: 5.422

7.  Human antibody response to Plasmodium falciparum merozoite surface protein 2 is serogroup specific and predominantly of the immunoglobulin G3 subclass.

Authors:  R R Taylor; D B Smith; V J Robinson; J S McBride; E M Riley
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

8.  Low CD4(+) T cell responses to the C-terminal region of the malaria merozoite surface protein-1 may be attributed to processing within distinct MHC class II pathways.

Authors:  S J Quin; E M Seixas; C A Cross; M Berg; V Lindo; B Stockinger; J Langhorne
Journal:  Eur J Immunol       Date:  2001-01       Impact factor: 5.532

9.  Mechanisms underlying the monocyte-mediated antibody-dependent killing of Plasmodium falciparum asexual blood stages.

Authors:  H Bouharoun-Tayoun; C Oeuvray; F Lunel; P Druilhe
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

10.  Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum.

Authors:  A F Egan; J A Chappel; P A Burghaus; J S Morris; J S McBride; A A Holder; D C Kaslow; E M Riley
Journal:  Infect Immun       Date:  1995-02       Impact factor: 3.441

View more
  84 in total

1.  Immunological responses against Plasmodium falciparum Apical Membrane Antigen 1 vaccines vary depending on the population immunized.

Authors:  Kazutoyo Miura; Hong Zhou; Ababacar Diouf; Gregory Tullo; Samuel E Moretz; Joan A Aebig; Michael P Fay; Louis H Miller; Ogobara K Doumbo; Issaka Sagara; Alassane Dicko; Carole A Long; Ruth D Ellis
Journal:  Vaccine       Date:  2011-01-31       Impact factor: 3.641

2.  Factors associated with immunoglobulin G subclass polarization in naturally acquired antibodies to Plasmodium falciparum merozoite surface proteins: a cross-sectional survey in Brazilian Amazonia.

Authors:  Kézia K G Scopel; Cor J F Fontes; Marcelo U Ferreira; Erika M Braga
Journal:  Clin Vaccine Immunol       Date:  2006-07

3.  Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.

Authors:  Faith H A Osier; Gregory Fegan; Spencer D Polley; Linda Murungi; Federica Verra; Kevin K A Tetteh; Brett Lowe; Tabitha Mwangi; Peter C Bull; Alan W Thomas; David R Cavanagh; Jana S McBride; David E Lanar; Margaret J Mackinnon; David J Conway; Kevin Marsh
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

4.  A malaria serological map indicating the intersection between parasite antigenic diversity and host antibody repertoires.

Authors:  H A Giha; A A Nasr; N C Iriemenam; K Berzins; M Troye-Blomberg; D E Arnot; G Elghazali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-29       Impact factor: 3.267

5.  Low prevalence of antibodies to preerythrocytic but not blood-stage Plasmodium falciparum antigens in an area of unstable malaria transmission compared to prevalence in an area of stable malaria transmission.

Authors:  Gregory S Noland; Brett Hendel-Paterson; Xinan M Min; Ann M Moormann; John M Vulule; David L Narum; David E Lanar; James W Kazura; Chandy C John
Journal:  Infect Immun       Date:  2008-09-22       Impact factor: 3.441

6.  Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens.

Authors:  Marta Vidal; Ruth Aguilar; Joseph J Campo; Carlota Dobaño
Journal:  J Immunol Methods       Date:  2018-01-31       Impact factor: 2.303

7.  Acquisition of antibodies to merozoite surface protein 3 among residents of Korogwe, north eastern Tanzania.

Authors:  Method D Segeja; Bruno P Mmbando; Misago D Seth; John P Lusingu; Martha M Lemnge
Journal:  BMC Infect Dis       Date:  2010-03-08       Impact factor: 3.090

8.  Antigen-specific influence of GM/KM allotypes on IgG isotypes and association of GM allotypes with susceptibility to Plasmodium falciparum malaria.

Authors:  Hayder A Giha; Amre Nasr; Nnaemeka C Iriemenam; David Arnot; Marita Troye-Blomberg; Thor G Theander; Klavs Berzins; Gehad ElGhazali; Janardan P Pandey
Journal:  Malar J       Date:  2009-12-22       Impact factor: 2.979

Review 9.  How might infant and paediatric immune responses influence malaria vaccine efficacy?

Authors:  A M Moormann
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

10.  The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria.

Authors:  David Courtin; Mayke Oesterholt; Harm Huismans; Kwadwo Kusi; Jacqueline Milet; Cyril Badaut; Oumar Gaye; Will Roeffen; Edmond J Remarque; Robert Sauerwein; André Garcia; Adrian J F Luty
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.